Yukang Mm Tan

Yukang Mm Tan

Auto-generated profile, based on publicly available information

Yukang Mm Tan

Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Guangdong, People’s Republic of China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2023 in Medicine
Verified
Journal Article
Open access
YTYukang Mm Tan
Yukang Mm Tan
CZchunguo zhang
chunguo zhang
CTChaohua Mm Tang
Chaohua Mm Tang
ZLZhijian Mm Li
Zhijian Mm Li
WCWensheng Mm Chen
Wensheng Mm Chen
HGHuagui Mm Guo
Huagui Mm Guo
The differences and correlation of biochemical indexes between bipolar disorder (BPD) and major depressive disorder (MDD) in stable stage were analyzed and discussed. Patients diagnosed with BPD and MDD in the Third People’s Hospital of Foshan from January 2019 to December 2021 were selected as the research subjects, with 200 cases in each. Fasting serum was collected from patients and then detected regarding TC, TG, high-density lipoprotein, low-density lipoprotein (LDL), aspartate aminotransferase, lactic dehydrogenase, creatine kinase, creatine kinase-MB, urea, creatinine, uric acid, alanine aminotransferase, glucose (GLU), hemoglobin A1c, prolactin, high-sensitivity C-reactive protein, homocysteine. The results showed that the mean age and serum LDL, GLU, and HbAc1 levels of the MDD group were significantly higher than those of the BPD group (P < .05), while there was no significant difference in other indexes (P > .05). The prevalence of BPD was significantly negatively correlated with patient age (r = −0.164, P = .020), LDL (r = −0.150, P = .034), GLU (r = −0.140, P = .048), and HbAc1 (r = −0.215, P = .002) (P < .05). There were no significant differences in serum Hcy and high-sensitivity C-reactive protein levels between the BPD and MDD groups. The age, fasting blood glucose, glycosylated hemoglobin, and LDL of BPD patients were negatively correlated with their incidence.

30 January 2026 in Medicine
Verified
Journal Article
Open access
JZJieyu Zhou
Jieyu Zhou
YTYukang Tan
Yukang Tan
SHShasha Huang
Shasha Huang
YZYajie Zhang
Yajie Zhang
JLJiaquan Liang
Jiaquan Liang
Major depressive disorder (MDD) is a common chronic mental illness. Long-term treatment of MDD may lead to changes in internal factors, which may exacerbate obesity. Nevertheless, the metabolic abnormalities associated with MDD across various age groups remain poorly understood. To identify factors related to obesity in MDD patients of all ages during stable treatment, we collected 205 MDD patients divided into adolescent depression (10 ≤ age < 19), adult MDD (19 ≤ age < 60), and late-life depression (60 ≤ age), recorded their names, gender, and age, and then measured their weight, height, body mass index (BMI), and the metabolic indexes of obesity. Finally, the statistical analysis of these indicators was carried out to clarify the relationship between them. The results show that among MDD, with the increase of age, the risk of obesity increases. BMI was positively correlated with age, total cholesterol, triglyceride, low-density lipoprotein, aspartate aminotransferase, lactate dehydrogenase, uric acid, alanine aminotransferase, glycosylated hemoglobin, and high-sensitivity C-reactive protein, and negatively correlated with high-density lipoprotein. But creatine kinase isoenzyme, urea, serum creatinine, and homocysteine were not correlated with BMI. Multiple linear regression analysis showed that the value of BMI increased with the increase of age ( B = 0.050, P = .002), aspartate aminotransferase ( B = 0.094, P = .049), alanine aminotransferase ( B = 0.055, P = .016), uric acid ( B = 0.006, P < .021), glycosylated hemoglobin ( B = 0.702, P = .004), and high-sensitivity C-reactive protein ( B = 0.101, P < .001). In light of these findings, it is recommended that we should pay more attention to the monitoring of blood metabolism indicators with the increase of age in MDD, in order to facilitate timely clinical decision-making and reduce the risk of obesity in these individuals.